Literature DB >> 4415565

Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.

R O Brady, P G Pentchev, A E Gal, S R Hibbert, A S Dekaban.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4415565     DOI： 10.1056/NEJM197411072911901

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  53 in total

1.  Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisited.

Authors:  V Korablyov; A Zimran; Y Barenholz
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.

Authors:  R J Desnick; K J Dean; G Grabowski; D F Bishop; C C Sweeley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

3.  Alglucerase for Gaucher's disease: dose, costs and benefits.

Authors:  E Beutler; A M Garber
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

4.  Benefits from unearthing "a biochemical Rosetta Stone".

Authors:  Roscoe O Brady
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

5.  Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.

Authors:  U H Schueler; T Kolter; C R Kaneski; G C Zirzow; K Sandhoff; R O Brady
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

6.  Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.

Authors:  E Beutler; G L Dale; D E Guinto; W Kuhl
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

7.  Enzyme replacement and gene therapy for Gaucher's disease.

Authors:  R O Brady; N W Barton
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 8.  Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease.

Authors:  R O Brady; G J Murray; N W Barton
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.

Authors:  Y Sato; E Beutler
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels.

Authors:  You-Hai Xu; Rachel Reboulet; Brian Quinn; Joerg Huelsken; David Witte; Gregory A Grabowski
Journal:  Mol Genet Metab       Date:  2008-03-17       Impact factor: 4.797
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.